PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Cecilia Larocca

Harvard University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews1 Guidelines1

Latest

Everything in the corpus, newest first.

SEP 7, 2026 · REVIEW

Adverse events associated with systemic cutaneous T-cell lymphoma therapies: a narrative review

Frontiers in Medicine

A narrative review synthesizing adverse event profiles across 14 NCCN-recommended systemic therapies for cutaneous T-cell lymphoma, designed to inform clinical treatment selection and monitoring rather than report new efficacy data.

Expert GuidanceKrithika Nayudu Cecilia Larocca Lymphoma Diagnosis and Treatment

Study details

DesignNarrative review of Phase II and III trial…

InterventionFourteen systemic therapies: antibody-drug…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support